Bregvadze, I N <br/><br/>
[The efficacy and safety of nibentan for pharmacological cardioversion in patients with persistent atrial fibrillation and flutter: the role of dose limitation and magnesium sulfate administration].  [electronic resource] 

 -  Kardiologiia  2007 
 - 48-55 p.  digital 
<br/><br/> Publication Type: Comparative Study; Evaluation Study; Journal Article 
<br/><br/><label>ISSN: </label>0022-9040 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Anti-Arrhythmia Agents--administration & dosage<br/>Atrial Fibrillation--diagnosis<br/>Atrial Flutter--diagnosis<br/>Benzamides--administration & dosage<br/>Data Interpretation, Statistical<br/>Electrocardiography<br/>Female<br/>Humans<br/>Magnesium Sulfate--administration & dosage<br/>Male<br/>Middle Aged<br/>Retrospective Studies<br/>Time Factors<br/>Torsades de Pointes--chemically induced<br/>Treatment Outcome